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Abstract 
Tumour invasion and metastasis have been recognized as major causal factors in the 
morbidity and mortality among cancer patients. Many advances in the knowledge of cancer 
metastasis have yielded an impressive array of attractive drug targets, including enzymes, 
receptors and multiple signalling pathways. The present review summarizes the molecular 
pathogenesis of metastasis and the identification of novel molecular targets used in the 
discovery of antimetastatic agents. Several promising targets have been highlighted, 
including receptor tyrosine kinases, effector molecules involved in angiogenesis, matrix 
metalloproteinases (MMPs), urokinase plasminogen activator, adhesion molecules and their 
receptors, signalling pathways (e.g. phosphatidylinositol 3-kinase, phospholipase Cγ1, 
mitogen-activated protein kinases, c-Src kinase, c-Met kinases and heat shock protein. The 
discovery and development of potential novel therapeutics for each of the targets are also 
discussed in this review. Among these, the most promising agents that have shown 
remarkable clinical outcome are anti-angiogenic agents (e.g. bevacizumab). Newer agents, 
such as c-Met kinase inhibitors, are still undergoing preclinical studies and are yet to have 
their clinical efficacy proven. Some therapeutics, such as first-generation MMP inhibitors 
(MMPIs; e.g. marimastat) and more selective versions of them (e.g. prinomastat, tanomastat), 
have undergone clinical trials. Unfortunately, these drugs produced serious adverse effects 
that led to the premature termination of their development. In the future, third-generation 
MMPIs and inhibitors of signalling pathways and adhesion molecules could form valuable 
novel classes of drugs in the anticancer armamentarium to combat metastasis. 
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